Background <p>Intra-abdominal desmoid tumours (IADT) can closely mimic gastrointestinal stromal tumours (GISTs), particularly in recurrence and metastases. However, differentiating these two diseases using radiological methods remains challenging. This study aimed to investigate the value of [<sup>18</sup>F]FAPI-42 PET/CT in differentiating IADT and GISTs compared to [<sup>18</sup>F]FDG PET/CT. </p> Methods <p>This study retrospectively included a total of 24 patients (12 patients with IADT and 12 patients with recurrent/metastatic GISTs) who underwent two separate PET/CT scans using [<sup>18</sup>F]FAPI-42 and [<sup>18</sup>F]FDG, respectively. The differences in tumour SUV<sub>max</sub> on [<sup>18</sup>F]FAPI-42 PET/CT (SUV<sub>max</sub>-FAPI) and [<sup>18</sup>F]FDG PET/CT (SUV<sub>max</sub>-FDG) and the ratio of tumour SUV<sub>max</sub> on FAPI PET/CT to SUV<sub>max</sub> on FDG PET/CT [SUV<sub>max</sub> ratio (FAPI/FDG)] were compared between IADT and GISTs. Receiver operating characteristic (ROC) curve analyses were performed to evaluate the diagnostic performance of these parameters in differentiating IADTs from GISTs. Immunohistochemistry was used to verify FAP expression in all IADT lesions and GISTs lesions.</p> Results <p>The SUV<sub>max</sub> of IADTs on [<sup>18</sup>F]FAPI-42 PET/CT was significantly higher than that of GISTs [<b>8.8 (7.2</b>,<b> 10.6) vs. 3.9 (2.8</b>,<b> 7.6)</b>, <Emphasis Type="BoldItalic">P</Emphasis> <b>= 0.045</b>], whereas the SUV<sub>max</sub> of IADTs on [<sup>18</sup>F]FDG PET/CT was significantly lower than that of GISTs [<b>2.5 (1.9</b>,<b> 3.5) vs. 6.1 (3.6</b>,<b> 8.3)</b>, <Emphasis Type="BoldItalic">P</Emphasis> <b>= 0.007</b>]. The SUV<sub>max</sub> ratio (FAPI/FDG) of IADTs was significantly higher than that of GISTs [<b>3.3 (2.2</b>,<b> 4.1) vs. 0.8 (0.3</b>,<b> 1.4)</b>, <Emphasis Type="BoldItalic">P</Emphasis> <b>&lt; 0.001</b>]. SUV<sub>max</sub>-FAPI, SUV<sub>max</sub>-FDG, and the SUV<sub>max</sub> ratio (FAPI/FDG) achieved AUCs of 0.743, 0.819, and 0.896, with corresponding accuracies of 75.0%, 83.3%, and 87.5%, respectively, for distinguishing IADT from GISTs. Immunohistochemistry revealed significantly higher FAP expression in IADTs compared to GISTs (<Emphasis Type="BoldItalic">P</Emphasis> <b>= 0.002</b>), with most IADTs showing strong (3+) staining (8/12, 66.7%), while GISTs primarily demonstrated weak (1+) or no staining (7/12, 58.3%).</p> Conclusion <p>The distinct uptake characteristics of [<sup>18</sup>F]FAPI-42 and [<sup>18</sup>F]FDG observed in IADTs and GISTs provide preliminary evidence that these two tracers may offer complementary diagnostic information when evaluating desmoid tumours that mimic recurrent or metastatic GISTs.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Differential [18F]FAPI-42 and [18F]FDG uptake patterns distinguish desmoid tumours from GISTs on PET/CT imaging

  • Chunhui Wu,
  • Xiaoyan Wang,
  • Xiaojie Lin,
  • Andor W. J. M. Glaudemans,
  • Bart Cornelissen,
  • Walter Noordzij,
  • Xin Hu,
  • Yu Zeng,
  • Xiangsong Zhang,
  • Xinhua Zhang

摘要

Background

Intra-abdominal desmoid tumours (IADT) can closely mimic gastrointestinal stromal tumours (GISTs), particularly in recurrence and metastases. However, differentiating these two diseases using radiological methods remains challenging. This study aimed to investigate the value of [18F]FAPI-42 PET/CT in differentiating IADT and GISTs compared to [18F]FDG PET/CT.

Methods

This study retrospectively included a total of 24 patients (12 patients with IADT and 12 patients with recurrent/metastatic GISTs) who underwent two separate PET/CT scans using [18F]FAPI-42 and [18F]FDG, respectively. The differences in tumour SUVmax on [18F]FAPI-42 PET/CT (SUVmax-FAPI) and [18F]FDG PET/CT (SUVmax-FDG) and the ratio of tumour SUVmax on FAPI PET/CT to SUVmax on FDG PET/CT [SUVmax ratio (FAPI/FDG)] were compared between IADT and GISTs. Receiver operating characteristic (ROC) curve analyses were performed to evaluate the diagnostic performance of these parameters in differentiating IADTs from GISTs. Immunohistochemistry was used to verify FAP expression in all IADT lesions and GISTs lesions.

Results

The SUVmax of IADTs on [18F]FAPI-42 PET/CT was significantly higher than that of GISTs [8.8 (7.2, 10.6) vs. 3.9 (2.8, 7.6), P= 0.045], whereas the SUVmax of IADTs on [18F]FDG PET/CT was significantly lower than that of GISTs [2.5 (1.9, 3.5) vs. 6.1 (3.6, 8.3), P= 0.007]. The SUVmax ratio (FAPI/FDG) of IADTs was significantly higher than that of GISTs [3.3 (2.2, 4.1) vs. 0.8 (0.3, 1.4), P< 0.001]. SUVmax-FAPI, SUVmax-FDG, and the SUVmax ratio (FAPI/FDG) achieved AUCs of 0.743, 0.819, and 0.896, with corresponding accuracies of 75.0%, 83.3%, and 87.5%, respectively, for distinguishing IADT from GISTs. Immunohistochemistry revealed significantly higher FAP expression in IADTs compared to GISTs (P= 0.002), with most IADTs showing strong (3+) staining (8/12, 66.7%), while GISTs primarily demonstrated weak (1+) or no staining (7/12, 58.3%).

Conclusion

The distinct uptake characteristics of [18F]FAPI-42 and [18F]FDG observed in IADTs and GISTs provide preliminary evidence that these two tracers may offer complementary diagnostic information when evaluating desmoid tumours that mimic recurrent or metastatic GISTs.